Adriana Tomic

Employment

• Boston University Assistant Professor
  2022 - Present
• Stanford University
  2017 - Present
• Hochschule Hannover Research Fellow
  2013 - Present
• University of Oxford

Education

• Hochschule Hannover PhD
  2013 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (23)

• CD4+ and CD8+ T cells and antibodies are associated with protection against Delta vaccine breakthrough infection: a nested case-control study within the PITCH study
  mBio 2023 DOI: 10.1128/mbio.01212-23
  +Save
• Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history
  Nature Communications 2023 DOI: 10.1038/s41467-023-40592-4
  +Save
• Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
  Christos P. Kotanidis, Cheng Xie, Donna Maria Alexander

  +97 more

  • Jonathan C. L. Rodrigues
  • Katie L. Burnham
  • Alexander J. Mentzer
  • Daniel O’Connor
  • Julian Charles Knight
  • +92 more
  The Lancet Digital Health 2022 DOI: 10.1016/s2589-7500(22)00132-7
  +Save
• Divergent trajectories of antiviral memory after SARS-CoV-2 infection
  Adriana Tomić, Donal Skelly, Ane Ogbe +97 more
  Nature Communications 2022 DOI: 10.1038/s41467-022-28898-1
  +Save
• A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
  David Ahern, Zhichao Ai, Mark Andrew Ainsworth +97 more
  Cell 2022 DOI: 10.1016/j.cell.2022.01.012
  +Save
• MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination
  Cellular & Molecular Immunology 2022 DOI: 10.1038/s41423-021-00814-5
  +Save
• Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
  Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold +97 more
  Nature Medicine 2021 DOI: 10.1038/s41591-021-01372-z
  +Save
• Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
  Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer +97 more
  Nature Medicine 2021 DOI: 10.1038/s41591-021-01363-0
  +Save
• Systems Immunology: Revealing Influenza Immunological Imprint
  Viruses 2021 DOI: 10.3390/v13050948
  +Save
• Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
  Merryn Voysey, Sue Ann Costa Clemens, Shabir Ahmed Madhi +97 more
  The Lancet 2021 DOI: 10.1016/s0140-6736(21)00432-3
  +Save
• Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
  Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold +97 more
  Nature Medicine 2021 DOI: 10.1038/s41591-020-01179-4
  +Save
• T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
  Katie Ewer, Jordan R. Barrett, Sandra Belij‐Rammerstorfer +97 more
  Nature Medicine 2021 DOI: 10.1038/s41591-020-01194-5
  +Save
• SIMON: Open-Source Knowledge Discovery Platform
  Patterns 2021 DOI: 10.1016/j.patter.2020.100178
  +Save
• Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
  Merryn Voysey, Sue Ann Costa Clemens, Shabir Ahmed Madhi +97 more
  The Lancet 2021 DOI: 10.1016/s0140-6736(20)32661-1
  +Save
• Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
  Maheshi Ramasamy, Angela M. Minassian, Katie Ewer +97 more
  The Lancet 2020 DOI: 10.1016/s0140-6736(20)32466-1
  +Save
• Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
  Molecular Systems Biology 2020 DOI: 10.15252/msb.20209888
  +Save
• The FluPRINT dataset, a multidimensional analysis of the influenza vaccine imprint on the immune system
  Scientific Data 2019 DOI: 10.1038/s41597-019-0213-4
  +Save
• SIMON, an Automated Machine Learning System, Reveals Immune Signatures of Influenza Vaccine Responses
  The Journal of Immunology 2019 DOI: 10.4049/jimmunol.1900033
  +Save
• Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells
  Nature Immunology 2018 DOI: 10.1038/s41590-018-0082-6
  +Save
• Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand
  PLoS Pathogens 2016 DOI: 10.1371/journal.ppat.1006015
  +Save